deltatrials
Completed OBSERVATIONAL NCT03590275

Observational Retrospective Study of Evaluation of Prognostic Factors in Advanced Pancreatic Cancer Patients Treated With FOLFIRINOX (HOPE)

Sponsor: Azienda Ospedaliero, Universitaria Pisana

Conditions Pancreatic Cancer Non-resectable
Interventions FOLFIRINOX
Updated 4 times since 2018 Last updated: Jul 6, 2018 Started: Oct 2, 2017 Primary completion: Jan 18, 2018 Completion: Jun 30, 2018
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Pancreatic Cancer Non-resectable, this trial is completed. The trial is conducted by Azienda Ospedaliero, Universitaria Pisana and has accumulated 4 data snapshots since 2017. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Aug 2018 – ~Jan 2021 · 29 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

4 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Jan 2021 — Jul 2024 [monthly]

    Completed

  4. Aug 2018 — Jan 2021 [monthly]

    Completed

    First recorded

Oct 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Azienda Ospedaliero, Universitaria Pisana
Data source: Azienda Ospedaliero, Universitaria Pisana

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations